PXR is efficaciously activated by several steroids, including naturally occurring pregnanes and synthetic glucocorticoids and antiglucocorticoids. Thus, PXR combines features of both the steroid and nonsteroid nuclear receptors. We suggest that PXR defines a novel steroid hormone signaling pathway that may account for at least some of the effects of synthetic glucocorticoids and antiglucocorticoids that do not appear to be mediated through the classical glucocorticoid receptor (GR) signaling pathway.
Results

Cloning of PXR.1 and PXR.2
In an effort to identify new members of the nuclear receptor family, we performed a series of motif searches of public EST databases. These searches revealed a clone from a mouse liver library in the Washington University/HHMI EST database that had homology to the ligand-binding domains (LBDs) of a number of nuclear receptors. We used this partial sequence information to isolate larger clones from a mouse liver cDNA library. The nucleotide sequence of the longest cDNA clone encodes a novel orphan nuclear receptor of 431 amino acids that we have designated PXR.1 ( Figure 1A ). We also isolated a second cDNA clone, termed PXR.2, that was identical to PXR.1 except for the deletion of a stretch of 123 nucleotides extending from base pairs 661 to 783 ( Figure 1A) . Examination of the PXR genomic structure revealed that PXR.2 represents a splice variant of PXR.1 lacking a single exon (data not shown). The PXR.2 cDNA encodes a 390 amino acid protein that lacks a 41 amino acid region in the putative LBD of PXR.1. Sequence alignment with nuclear receptors for which the crystal structures have been solved indicates that the 41 amino acids that distinguish the PXR isoforms lie between helices two and three of the canonical LBD structure (Wurtz et al., 1996) .
Sequence comparison with other members of the nuclear receptor family showed that the PXR isoforms are most closely related to the Xenopus laevis orphan nuclear receptor 1 (ONR1) (Smith et al., 1994) , with PXR.2 and ONR1 sharing 70% and 46% amino acid identity in D receptor (VDR) (Baker et al., 1988) , sharing 64% and (B) Amino acid sequence comparison between murine PXR and 39% identity in the DBD and LBD, respectively. other members of the nuclear hormone receptor family. Similarity between PXR and other nuclear hormone receptor family members in the DNA-and ligand-binding domains are indicated as percent that included poly(A) ϩ RNA prepared from multiple adult mouse tissues and a probe that recognized both PXR isoforms. Abundant expression of PXR mRNA was oband 4.4 kb that were expressed at lower levels ( Figure  2A ). Weaker expression of the PXR mRNA was also served only in the liver and intestine, where three distinct messages were detected including a highly expressed detected in kidney and stomach ( Figure 2A ). No PXR mRNA was detected in the other tissues examined. mRNA species of 2.6 kb and two transcripts of 1.9 kb
PXR Expression Pattern in the Embryo
PXR Is Activated by Synthetic Pregnanes and Glucocorticoids
We next sought to determine whether PXR, like other members of the nuclear receptor family, possesses transcriptional activity that can be regulated in a hormonedependent manner. As we lacked knowledge of a cognate HRE for PXR, we initially performed searches for activators using an established chimera system in which the LBDs of the two PXR isoforms were fused to the DBD of the yeast transcription factor GAL4 (Lehmann et al., 1995) . Expression vectors for the GAL4-PXR chimeras were transiently transfected into CV-1 cells together with a reporter plasmid containing five copies of a GAL4 DNA binding site upstream of the chloramphenicol acetyltransferase (CAT) reporter. Transfected CV-1 cells were systematically treated with a series of natural and synthetic compounds that included steroids, vitamin D analogs, thyroid hormone analogs, retinoids, fatty acids, and other small, lipophilic molecules, and reporter levels measured.
Interestingly, we found that the activity of the GAL4-PXR.1 chimera was markedly induced by 10 M concentrations of a variety of synthetic steroids including the glucocorticoids dexamethasone, dexamethasone-tbutyl-acetate, and dexamethasone-21-acetate, and the pregnenolone derivative 6,16␣-dimethyl pregnenolone ( Figure 3B ). Dexamethasone-t-butylacetate and 6,16␣-dimethyl pregnenolone were the most efficacious of these compounds ( Figure 3B ). Remarkably, we found that PXR.1 was not only activated by GR agonists, but also by the acetate activated GAL4-PXR.2 efficiently ( Figure 3B ). We conclude that the 41 amino acid deletion that distinThe embryonic expression pattern of PXR was examguishes PXR.2 from PXR.1 has a marked effect on the ined via in situ hybridization analysis using sections preresponsiveness of the orphan receptor to synthetic stepared from day 18 (E18) mouse embryos. Three oligonuroids. cleotide probes were designed that recognized PXR, including two that interacted with both PXR isoform PXR Functions through a Response Element mRNAs and a third that hybridized only to PXR.1 mRNA.
Conserved in the CYP3A Gene Promoters PXR mRNA was detected in the liver and intestine (Fig-PCN and dexamethasone treatment have previously ures 2B-2D). Staining in the intestine was confined to been shown to induce the expression of the CYP3A the epithelium ( Figure 2D ). No PXR expression was defamily of genes in rodent liver, intestine, and kidney tected in embryonic kidney, adrenal, lung, thymus, heart, as well as in primary cultures of rodent hepatocytes skeletal muscle, brain, or spinal cord (data not shown).
(Elshourbagy and Guzelian, 1980; Heuman et al., 1982 ; While similar results were obtained with all three PXR Hardwick et al., 1983; Schuetz and Guzelian, 1984 ; probes, the signal intensity in liver and intestine was Schuetz et al., 1984; Gonzalez et al., 1985 ; Debri et consistently higher in experiments performed with the al., 1995). The CYP3A genes encode cytochrome P450 probes that recognize both PXR isoforms (data not hemoproteins involved in the hydroxylation of steroid shown), suggesting that PXR.2 is expressed in tissues hormones, including corticosteroids, progestins, androthat also express PXR.1. We conclude from the Northern gens, and DHEA-sulfate, as well as a variety of xenobiotblot and in situ hybridization analyses that PXR is abunics (Nebert and Gonzalez, 1987; Juchau, 1990) . The redantly expressed in only a few tissues, including the liver and intestine, in both the mouse embryo and adult.
sponse to PCN and dexamethasone occurs at the level by a three-nucleotide spacer, a so-called DR-3 motif ( Figure 4A ) (Umesono et al., 1991; Miyata et al., 1995; Huss et al., 1996) . These data efficiently to the CYP3A1 DR-3 as heterodimers with RXR␣ ( Figure 4B ). The PXR-RXR␣ complex with DNA have led to speculation that a nonsteroid nuclear hormone receptor might be involved in mediating the efwas competed efficiently by an excess of unlabeled CYP3A1 DR-3 oligonucleotide or an oligonucleotide fects of PCN and dexamethasone.
Given that PXR shares a high degree of homology containing a closely related DR-3 motif from the CYP3A2 gene promoter (Figures 4A and 4C) . No competition was with ONR1 and VDR in the DBD ( Figure 1B ) and that both ONR1 and VDR preferentially bind to DR-3 HREs seen with an oligonucleotide containing a mutated CYP3A1 DR-3 motif ( Figures 4A and 4C ). Thus, both as heterodimers with RXR (Umesono et al., 1991; Smith et al., 1994; Mangelsdorf and Evans, 1995) , we postu-PXR isoforms can bind specifically as heterodimers with RXR␣ to DR-3 motifs found in the promoter regions of lated that PXR might bind to the CYP3A1 and CYP3A2 DR-3 motifs as a heterodimer with RXR. In order to test CYP3A genes. We next asked whether the PXR isoforms could inthis idea, gel mobility shift assays were performed using a radiolabeled oligonucleotide containing the CYP3A1 duce gene expression through the CYP3A1 DR-3 element in response to steroids. Transient transfection DR-3 motif and in vitro synthesized PXR.1, PXR.2, and RXR␣. Neither PXR nor RXR␣ bound to the CYP3A1 assays were performed with a reporter plasmid containing two copies of the CYP3A1 DR-3 motif inserted DR-3 alone. However, both PXR.1 and PXR.2 bound activated by dexamethasone-t-butylacetate ( Figure 5A ). Dose-response analysis revealed dexamethasone-tbutylacetate to be a significantly more potent activator of PXR.1 than PXR.2, with EC 50 values of 0.8 and 5 M for PXR.1 and PXR.2, respectively ( Figures 5B and 5C ). Consistent with the results obtained using the GAL4-PXR chimeras, 6,16␣-dimethyl pregnenolone, PCN, and RU486 activated full-length PXR.1 on the CYP3A1 response element but failed to activate full-length PXR.2 ( Figures 5B and 5C ). 6,16␣-dimethyl pregnenolone was the most potent of these compounds, activating PXR.1 with an EC50 value of 300 nM ( Figure 5B ). Based upon these data, we conclude that the full-length PXR isoforms can activate gene expression through the CYP3A1 DR-3 motif in response to synthetic steroids.
PXRs Are Activated by Naturally Occurring Steroids
As PXR was activated by synthetic steroids, we examined whether a naturally occurring steroid might serve as the endogenous hormone for PXR. Accordingly, CV-1 cells were transfected with expression plasmids for either of the full-length PXR isoforms and the (CYP3A1) 2 -tk-CAT reporter and treated with a variety of natural steroids, including progestins, glucocorticoids, mineralocorticoids, androgens, estrogens, bile acids, and oxysterols. Both PXR.1 and PXR.2 were activated by micromolar concentrations of certain of these steroids. Consistent with our findings that the pregnenolone derivatives 6,16␣-dimethyl pregnenolone and PCN activate PXR.1, pregnenolone and its metabolites 17␣-hydroxypregnenolone, progesterone, 17␣-hydroxyprogesterone, and 5␤-pregnane-3,20-dione activated PXR.1 ( Figure  6B ). Dose-response analysis revealed that all five of these pregnanes activated PXR.1 with EC 50 values in the 5-20 M range ( Figure 6C ). Since PXR.1 is activated by synthetic glucocorticoids, we were surprised to find that naturally occurring glucocorticoids, including cortisol and corticosterone, had virtually no effect on PXR.1 activity (data not shown).
In analogous cotransfection experiments performed 
with a Coactivator Protein
We next sought to address whether the steroids that activated PXR did so through direct interactions with upstream of the minimal thymidine kinase promoter and the LBD. Due to the lack of radiolabeled derivatives the CAT gene [(CYP3A1) 2 -tk-CAT]. Interestingly, in the of the more potent PXR activators, we were unable to absence of steroids, PXR.1 was found to have a roughly perform standard binding analyses. However, a number 20-fold higher basal level of activity than PXR.2 ( Figure  5A ). Nevertheless, both PXR isoforms were efficiently of laboratories have recently demonstrated that ligands and nonsteroid nuclear hormone receptors in a liganddependent fashion (Onate et al., 1995; Horwitz et al., 1996; Kamei et al., 1996; Takeshita et al., 1996) . The interaction of SRC-1 with nuclear receptors is dependent upon the amino acid motif LXXLL found in multiple copies in SRC-1 (Heery et al., 1997; Torchia et al., 1997) .
In an effort to determine whether the steroid activators of PXR serve as ligands for this orphan receptor, we tested whether a 14 kDa fragment of SRC-1 (SRC-1.14) containing three LXXLL motifs interacted with PXR in a steroid-dependent manner. SRC-1.14 was expressed in vitro and labeled with [
S]-methionine and [
35 S]-cysteine, and the LBD of PXR.1 was expressed in E. coli as a fusion protein with glutathione-S-transferase (GST). Coprecipitation experiments were performed in the presence of the most potent PXR activators including 6,16␣-dimethyl pregnenolone, dexamethasone-t-butylacetate, and PCN. [ 35 S]-SRC-1.14 interacted only weakly with the GST-PXR.1LBD fusion protein in the absence of added compound ( Figure 7A ). The interaction of [
35 S]-SRC-1.14 with GST-PXR.1LBD was significantly enhanced in the presence of either dexamethasone-t-butylacetate, 6,16␣-dimethyl pregnenolone, or PCN ( Figure 7A) . Additional experiments performed with 6,16␣-dimethyl pregnenolone and PCN revealed that these steroids promoted [ 35 S]-SRC-1.14/PXR.1LBD interactions in a dose-dependent manner ( Figure 7B ). Consistent with the results of the transfection studies, 6,16␣-dimethyl pregnenolone was more potent than PCN in promoting these interactions ( Figure 7B ). Estradiol did not stimulate interactions between PXR.1 and [ 35 S]-SRC-1.14, indicating that the enhancement was specific for compounds that activate PXR.1 in the transfection assay ( Figure 7A ous drugs is sex dependent, that castration of rodents leads to increased drug sensitivity, and that liver homogenates of intact male rats metabolize certain drugs more for nuclear receptors induce their interaction with prorapidly than homogenates prepared from castrated aniteins required for optimal transcriptional activation, the mals led to the concept of "catatoxic" steroids; that so-called coactivator proteins (Horwitz et al., 1996) .
Identification of a Novel Signaling Pathway
is, steroids that confer resistance to specific toxins by These ligand-dependent interactions have been exaccelerating their metabolism (reviewed by Kourounakis ploited as a biochemical assay for demonstrating direct et al., 1977) . It was speculated that catatoxic agents interactions between ligands and their cognate recepmight have utility in the treatment of patients suffering tors (Krey et al., 1997) .
from either drug intoxication or from diseases caused The steroid receptor coactivator protein-1 (SRC-1) by endogenous substances liable to metabolism (e.g., Cushing's syndrome) (Kourounakis et al., 1977) . has been shown to interact directly with both steroid . This response element was composed of two copies of the nuclear receptor half-site consensus sequence AGTTCA organized as a DR.
In addition to PCN, the expression of CYP3A1 was also shown to be induced by dexamethasone both in vivo and in cultured hepatocytes (Heuman et al., 1982; Schuetz and Guzelian, 1984; Schuetz et al., 1984) . However, the concentrations of dexamethasone required to induce CYP3A gene expression were higher than those typically required to activate the classical GR signaling pathway (Schuetz and Guzelian, 1984; Schuetz et al., 1984) . Promoter mapping studies showed that dexamethasone induced CYP3A1 gene expression through the same DR response element as PCN (Quattrochi et al., 1995; Huss et al., 1996) . Thus, paradoxically, both high concentrations of dexamethasone, a glucocorticoid, and PCN, an antiglucocorticoid, induced the expression of the CYP3A1 gene through the same response element.
We now provide several lines of evidence indicating that the orphan nuclear receptor PXR is responsible for mediating the inductive effects of PCN and dexamethasone on CYP3A gene expression. First, both dexamethasone and PCN are efficacious activators of the PXR.1 isoform. Second, PXR binds efficiently as a heterodimer nificant decreases in the levels of HMG-CoA reductase and cholesterol 7␣-hydroxylase gene expression with A systematic analysis of steroids in the early 1970s concomitant reductions in sterol biosynthesis and bile identified the pregnenolone derivative PCN as the most acid secretion (von Bergmann et al., 1975; Mason and Boyd, 1978; Turley and Dietschy, 1984; Stahlberg, 1995) . potent catatoxic compound among those tested (Selye, 1971) . Insight into the mechanism underlying the cata-PCN has also been reported to enhance the formation of cholesterol-esters and the hypersecretion of cholesterol toxic effects of PCN was provided by the demonstration that this synthetic steroid induces the expression of into the bile (von Bergmann et al., 1975; Turley and Dietschy, 1984) . Thus, PCN affects key aspects of cho-CYP3A1 and CYP3A2, two closely related members of the P450 family of monooxygenases (Elshourbagy and lesterol metabolism including its biosynthesis, storage, and secretion. Although we cannot exclude the possibil- Guzelian, 1980; Heuman et al., 1982; Hardwick et al., 1983; Schuetz and Guzelian, 1984; Schuetz et al., 1984;  ity that some of its biological effects might be mediated through the GR or other steroid receptors, it is tempting Gonzalez et al., 1985) . The CYP3A hemoproteins have a remarkably broad substrate specificity, hydroxylating to speculate that PCN is mimicking the actions of an endogenous hormone that serves to regulate coordia variety of xenobiotics such as cyclosporin, warfarin, and erythromycin, as well as endogenous steroids innately steroid and sterol metabolism through the activation of PXR in tissues such as liver and intestine. Our cluding cortisol, progesterone, testosterone, and DHEAsulfate (Nebert and Gonzalez, 1987; Juchau, 1990) . Subdata raise the possibility of the existence of regulatory loops through which endogenous PXR hormones feed sequent studies with the cloned CYP3A1 gene promoter identified a PCN response element that was highly conback to regulate cholesterol homeostasis and feed forward to regulate steroid homeostasis. Wichmann et al., 1984; Tietz, 1995) . While
Trapper solution hybridization cloning technology (GIBCO-BRL).
progesterone levels in human serum are generally in Five clones were obtained that ranged in size from 1.0 kb to 2.7 kb. the 1-10 nM range, concentrations can exceed 700 nM Four of these clones encoded PXR.1 and one encoded the DBD during the third trimester of pregnancy (Tietz, 1995) . to activate PXR.1 are achieved either in serum or in tissues under normal physiological conditions. Our rePlasmids sults with PXR may thus be analogous to those obtained
The expression plasmids pSG5-GAL4-PXR.1LBD and pSG5-GAL4-with RXR, which was first shown to be activated by PXR.2LBD were generated by amplification of cDNA encoding amino acids 105-431 of PXR.1 or 105-390 of PXR.2 by PCR and micromolar concentrations of all-trans retinoic acid insertion into a modified pSG5 expression vector (Stratagene) con-(t-RA) prior to the identification of 9-cis RA as a hightaining DNA encoding the DBD of GAL4 (amino acids 1-147) and affinity ligand (Mangelsdorf et al., 1990; the SV40 Tag nuclear localization signal (APKKKRKVG) inserted 1992; Levin et al., 1992) . Based upon our findings that upstream of a multiple cloning site. The (UAS) 5 -tk-CAT reporter plas-PXR is activated by pregnenolone and its metabolites mid has been previously described (Lehmann et al., 1995) . The exand that the synthetic steroid 6,16␣-dimethyl pregnenopression vectors pSG5-PXR.1 and pSG5-PXR.2 were generated by lone activates PXR with an EC 50 value of 300 nM, we amplification of cDNA encoding amino acids 1-431 of PXR.1 or 1-390 of PXR.2 and insertion into pSG5. The reporter plasmid suggest that the natural PXR ligand is likely to be a (CYP3A1)2-tk-CAT was generated by insertion of two copies of a pregnane.
double-stranded oligonucleotide containing the CYP3A1 DR-3 RE (5Ј GATCAGACAGTTCATGAAGTTCATCTAGATC 3Ј) (Quattrochi et Huss et al., 1996) into the BamHI site of pBLCAT2 (Luckow With the isolation of the androgen receptor in 1988 and Schü tz, 1987) . The bacterial expression vector pGEX-PXR.1LBD (Chang et al., 1988; Lubahn et al., 1988) , receptors for was generated by PCR amplification of cDNA encoding amino acids 105-431 of PXR.1 and insertion into a pGEX-2T vector (Pharmacia) all of the known nuclear-acting steroid hormones had that had been modified to contain KpnI and NotI restriction sites. been cloned. However, studies performed during the The bacterial expression vector pGEX-ER␣LBD was generated by past two years with orphan members of the nuclear PCR amplification of cDNA encoding amino acids 251-595 of human receptor family have suggested that additional sterols ER␣ (Green et al., 1986 ) and insertion into pGEX-2T. The expression are likely to serve as mammalian hormones. For examplasmid for the SRC-1.14 fragment was generated by PCR amplificaple, the orphan receptors LXR and SF-1 were recently tion of DNA encoding amino acids 632-754 of human SRC-1 (Takeshown to be activated by physiological concentrations shita et al., 1996) and insertion into the expression vector pRSETC (Invitrogen). All constructs were confirmed by sequence analysis.
Perspectives
of several oxysterol metabolites of cholesterol (Janowski et al., 1996; Lala et al., 1997; Lehmann et al., 1997) .
Cotransfection Assays
While the biological role of LXR remains less clear, SF-1 CV-1 cells were plated in 24-well plates in DME medium suppleis essential for adrenal and gonadal development and mented with 10% charcoal-stripped fetal calf serum at a density of regulates the expression of genes required for steroido- We have now identified PXR as a novel member of the manufacturer's instructions. The medium was changed to DME the nuclear receptor family that is efficaciously activated medium supplemented with 10% delipidated calf serum (Sigma) and by both natural and synthetic steroids. The activation cells were incubated for an additional 24 hr. Cell extracts were profile of PXR is distinct from any of the other steroid prepared and assayed for CAT and ␤-galactosidase activities as hormone receptors identified to date, suggesting that described previously (Lehmann et al., 1995 
